ValuationViz

ARQT fund manager activity

Arcutis Biotherapeutics, Inc · Nasdaq. Reported by 2 tracked fund managers in their 13F filings, Q4 2025 to Q2 2026.

Q4 2025

ManagerActivitySharesValue% of portfolioFiled
Ron Baron - Baron CapitalNew504,700$14,656,4880.04%Feb 17, 2026

Newer quarters